Talc Product Verdict Could Spur Talc-Free Powder Market Growth
This article was originally published in The Tan Sheet
Executive Summary
J&J works to assure consumers of talc safety following a jury verdict ordering it to pay $72m in damages to the family of a woman who attributed her ovarian cancer to perineal use of the company's baby and body powders. Around 1,200 similar cases are pending against the firm in Missouri and New Jersey courts.
You may also be interested in...
Another Talc Cancer Jury Finds Against J&J As Claimants Line Up
The $55m decision comes less than three months after a $72m finding against J&J in a similar case tried in the same St. Louis court, but this one may bode more ominously for the firm's prospects in a long line of related cases to come, plaintiff's counsel suggests.
J&J Found Negligent In Suit Linking Talc To Cancer
While no monetary damages were awarded, a federal court jury in South Dakota found Johnson & Johnson negligent for failing to warn that talc in its body powders may be linked to cancer. However, the jury did not find that J&J’s products were defective without such a warning.
FDA: No Asbestos Found In Talc Products Sampled, But Results Limited
Following reports of asbestos in talc and talc-containing products overseas, FDA conducted a survey of suppliers and products on the U.S. market, finding no detectable levels of asbestos.